The activated clotting time in cardiac surgery: Should Celite or kaolin be used?

Interactive Cardiovascular and Thoracic Surgery

Volumn 24, Issue 4, 2017, Pages 549-554

  De Vries, Adrianus J ^a   Lansink Hartgring, Annemieke Oude ^a   Fernhout, Freek Jan ^a   Huet, Rolf C G ^a   Van Den Heuvel, Edwin R ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Aortic valve replacement; Cardiopulmonary bypass; Clinical; Coagulation; Coronary artery bypass grafting

Indexed keywords

HEPARIN; INFUSORIAL EARTH; KAOLIN; TRANEXAMIC ACID; ANTICOAGULANT AGENT;

ACTIVATED CLOTTING TIME; AGED; ANTICOAGULANT THERAPY; AORTIC VALVE REPLACEMENT; ARTICLE; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHEST TUBE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; THROMBIN TIME; HEART VALVE REPLACEMENT; MIDDLE AGED;

AGED; ANTICOAGULANTS; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DIATOMACEOUS EARTH; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HUMANS; KAOLIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WHOLE BLOOD COAGULATION TIME;

EID: 85018331016     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivw435     Document Type: Article

References (16)

1. Hattersly PG. Activated coagulation time of whole blood. JAMA 1966;196:436-40.
2. Babka R, Colby C, El-Etr A, Pifarre R. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg 1977;73:780-2.
3. Wang JS, Lin CY, Hung WT, Karp RB. Monitoring of heparin-induced anticoagulation with kaolin activated clotting time in cardiac surgical patients treated with aprotinin. Anesthesiology 1992;77:1080-84.
4. Dietrich W, Jochum M. Effect of Celite and kaolin on activated clotting time in the presence of aprotinin: Activated clotting time is reduced by binding of aprotinin to kaolin. J Thorac Cardiovasc Surg 1995;109:177-86.
5. Doherty TM, Shavelle RM, French WJ. Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory. Catheter Cardiovasc Interv 2005;65:330-7.
6. Chia S, Van Cott EM, Raffel C, Jang IK. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-Thrombin therapy during cardiac catheterisation. Thromb Haemost 2009;101:535-40.
7. Thenappan T, Swamy R, Shah A, Nathan S, Nichols J, Bond L et al. Interchangeability of activated clotting time value across different point of care systems. Am J Cardiol 2012;109:1379-82.
8. Gravlee GP, Case LD, Angert KC, Rogers AT, Miller GS. Variability of the activated clotting time. Anesth Analg 1988;67:469-72.
9. Bosch YPJ, Ganushchak YM, De Jong DS. Comparison of ACT point-ofcare measurements: repeatability and agreement. Perfusion 2006;21:27-31.
10. Avendano A, Ferguson JJ. Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. JACC 1994;23:907-10.
11. Flom-Halvorsen HI, Øvrum E, Abdelnoor M, Bjørnsen, Brosstad F. Assessment of heparin anticoagulation: Comparison of two commercially available methods. Ann Thorac Surg 1999;76:1012-7.
12. Bennet JA, Horrow JC. Activated coagulation time: one tube or two? J Cardiothorac Vasc Anesth 1996;10:471-3.
13. Davidson SJ, Woodhams B. Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass. Int Jnl Lab Hem 2011;33:614-6.
14. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 1994;108:1076-82.
15. Bechtel JFM, Prosch J, Sievers H-H, Bartels C. Is the kaolin or Celite activated clotting time affected by tranexamic acid? Ann Thorac Surg 2002;74:390-3.
16. Casati V, Della Valle P, Benussi S, Franco A, Gerli C, Baili P et al. Effects of tranexamic acid on postoperative bleeding and hematochemical variables in coronary surgery: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 2004;128:83-91.